Information:
Fel:
ID
14184
Beskrivning
The Depression in Alzheimer's Disease Study (DIADS); ODM derived from: https://clinicaltrials.gov/show/NCT00009191
Länk
https://clinicaltrials.gov/show/NCT00009191
Nyckelord
Versioner (1)
- 2016-04-03 2016-04-03 -
Uppladdad den
3 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Alzheimer Disease NCT00009191
Eligibility Alzheimer Disease NCT00009191
- StudyEvent: Eligibility
Similar models
Eligibility Alzheimer Disease NCT00009191
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
alzheimers disease
Item
diagnosis of probable alzheimer's disease (ad) by nincds/adrda criteria (mckann et al., 1984), with a mmse score greater than 10
boolean
C0002395 (UMLS CUI [1])
major depressive episode
Item
diagnosis of current major depressive episode (md), by dsm-iv, based on the scid-iv examination
boolean
C0024517 (UMLS CUI [1])
unipolar depression
Item
patients will be included even if they have a pre-ad history of unipolar depression
boolean
C0041696 (UMLS CUI [1])
antidepressants
Item
patients who currently are being treated with antidepressants but continue to meet criteria for md (i.e., have not responded to the medications) and who are willing to discontinue the other medication and enter the study also will be included
boolean
C0003289 (UMLS CUI [1])
residence
Item
currently residing in the community (own home,family member's home, or small group home) and agreeing to 13 weeks of followup in the study
boolean
C0237096 (UMLS CUI [1])
medical history
Item
stable medical history and general health, in the opinion of the study psychiatrist
boolean
C0262926 (UMLS CUI [1])
compliance behaviour
Item
a caregiver who knows the patient well (spends at least 10 hours per week with him or her), and who is in reasonably good health, agrees to participate as well
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
participant and his/her legal representative provide informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion:
boolean
C0680251 (UMLS CUI [1])
Medical contraindication sertraline
Item
use of sertraline is contraindicated, based on the food and drug administration package insert for sertraline
boolean
C1301624 (UMLS CUI [1,1])
C0074393 (UMLS CUI [1,2])
C0074393 (UMLS CUI [1,2])
schizophrenia; bipolar disorder; anxiety disorder
Item
patient has a lifetime diagnosis of schizophrenia, bipolar disorder, or pre-ad anxiety disorder, as determined by the scid
boolean
C0036341 (UMLS CUI [1])
C0005586 (UMLS CUI [2])
C0003469 (UMLS CUI [3])
C0005586 (UMLS CUI [2])
C0003469 (UMLS CUI [3])
Substance Use Disorder
Item
patient has a current substance use disorder, as determined by the scid
boolean
C0038586 (UMLS CUI [1])
suicidal; psychiatric hospitalization
Item
patient is acutely suicidal or requires inpatient psychiatric hospitalization, as determined by the study psychiatrist
boolean
C0438696 (UMLS CUI [1])
C0748061 (UMLS CUI [2])
C0748061 (UMLS CUI [2])
Medication dose changed Psychotropic Drugs cholinesterase inhibitor
Item
no psychotropic medicine dose changes, including cholinesterase inhibitors, after study entry
boolean
C1608430 (UMLS CUI [1,1])
C0033978 (UMLS CUI [1,2])
C0008425 (UMLS CUI [1,3])
C0033978 (UMLS CUI [1,2])
C0008425 (UMLS CUI [1,3])
antidepressant
Item
may enter with any drug except another antidepressant.
boolean
C0003289 (UMLS CUI [1])